MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma. - Wikidata - wikimedia - TriplyDB

MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.

MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.

http://www.wikidata.org/entity/Q37211943

about

Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths.

P2860

Q47338470-3324A071-D57E-482F-A547-FE3E35FD1F82

P2860

MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.

http://www.wikidata.org/entity/Q37211943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@en

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@nl

type

label

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@en

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@nl

prefLabel

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@en

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@nl

P1433

Q37211943-BA18B1B3-E3B1-43B1-9623-D9F60DF5FD69

P1476

Q37211943-14A63405-8DBC-4B21-B5B9-D2FD1753C1AE

P2093

Q37211943-088C4CD8-1CE1-486B-B639-74D98D67A9A8

Q37211943-0E35A2FA-8653-4299-8F33-BBD8231E851D

Q37211943-254031C3-3B40-49C0-A7E1-73C043C1D18F

Q37211943-2B37D7AD-C453-42A4-A162-1B17E92FF7A8

Q37211943-5756BCA8-D058-4988-985C-0B044E98C07A

Q37211943-649789BA-4F5E-4272-8669-637F54A6372E

Q37211943-909717AB-5450-41A9-84C8-782B1DC3F634

Q37211943-9B8E7194-F8E2-43BB-AB85-2D0090525A41

Q37211943-A4190D1B-9EF7-452D-A67E-4C94211BF42C

Q37211943-AB50E3A6-51B8-4E24-91DD-00AB5BCEC31F

P2860

Q37211943-08282670-7E19-45B0-86A8-C4F66E43B5D0

Q37211943-14D250D4-6E7B-453E-9898-2CF06E3BCDEE

Q37211943-19608BF4-35B8-44F0-B70D-D1CDE2A9C531

Q37211943-1DE8914B-DD54-47DA-842F-8DBABEC3A9F0

Q37211943-25A814BC-6ED5-484B-8B8B-E341C8C57B26

Q37211943-2A735FF1-B6B5-4D21-8B58-989C6C0E9EA6

Q37211943-31F0F006-7975-4A33-A544-52E1DA39DCE1

Q37211943-3A10BDC2-578B-4815-B698-0894B3AEE854

Q37211943-45C32D6E-E9FC-4F03-B5A0-6C5558275A2D

Q37211943-47E182C4-EC7C-4795-9A9B-7A20F3B68D3F

P2888

Q37211943-28C633F5-071E-45D8-9901-AD2A082B08B4

P304

Q37211943-1734C591-36B9-4C6C-8229-5DB3C0AEE6E0

P31

Q37211943-9AA71E8D-B361-4F0F-A133-D7B4D7C77D92

P356

Q37211943-C4EF55BA-BC43-41AC-A066-CB15D91128C8

P407

Q37211943-EDF82BA2-2BAA-423A-96E0-702F56FFE1D6

P478

Q37211943-B95DEDC8-F7D4-4218-802E-92078EDE3FF6

P577

Q37211943-8E899B00-8E1A-4D8A-9733-FAEC353B17E8

P5875

Q37211943-168F52FD-0F01-461A-BE3B-D3842081971E

P698

Q37211943-D01F7BD3-7BE9-4653-B723-BF60E182DE96

P932

Q37211943-5F0DFCC8-DBAF-48B0-9388-C12A4CAA1204

P356

P1433

Scientific Reports

P1476

MAL hypermethylation is a tiss ...... ssion in esophageal carcinoma.

@en

P2093

Huimin Yu

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Ming Dong

http://www.w3.org/2001/XMLSchema#string

Si Chen

http://www.w3.org/2001/XMLSchema#string

Stephen J Meltzer

http://www.w3.org/2001/XMLSchema#string

Xianling Feng

http://www.w3.org/2001/XMLSchema#string

Xiaojing Zhang

http://www.w3.org/2001/XMLSchema#string

Xinmin Fan

http://www.w3.org/2001/XMLSchema#string

Yan Gao

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation

Expression of the MAL gene in the thyroid: the MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles

Loss of MAL expression in precancerous lesions of the esophagus

Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.

Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus

Incidence of adenocarcinoma among patients with Barrett's esophagus.

P2888

P304

2838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP02838

http://www.w3.org/2001/XMLSchema#string

P407

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257309840

http://www.w3.org/2001/XMLSchema#string

P698

24088706

http://www.w3.org/2001/XMLSchema#string

P932

3789153

http://www.w3.org/2001/XMLSchema#string